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Reducing Smooth Muscle Hypertrophy Asthmatic
GI / Pulmonary Endoscopy Unit
SURVEY 1
Asthma, a chronic respiratory disease affects 25 million people in 
the U.S.  Severe asthma patients experience chronic inflammatory 
conditions of the airway characterized by periodic symptoms of 
breathlessness, coughing, wheezing, and chest tightness. Chronic 
airway inflammation can lead to an increase in thickness of airway 
smooth muscle (ASM), which causes airflow constriction and 
difficulty breathing.
Bronchial thermoplasty (BT) is an innovative procedure for 
a pulmonary endoscopist to treat adult patients with severe 
persistent asthmatic symptoms.
Procedure
Patients complete 3-4 outpatient procedures, 3 weeks apart. 
Each procedure treats a different area of the lung.
Pre Procedure:
•  Initiate prophylactic Oral Corticosteroids 3 days prior, day of, and 
day after procedure to prevent asthmatic exacerbation.
•  Perform Pulmonary Function Test (PFT) the morning of procedure 
to assess stability of the airway and prevent flair up during and 
post procedure. 
Background
•  No further exacerbation or flares since procedure:
   –  “I was walking and biking two days later.”
   –  “You changed my life.”
   –  “I can’t stop moving.”
•  No further Prednisone
Patient Outcomes
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Procedure Outcome
Bronchial thermoplasty, a non-drug therapy, is expected to 
complement the asthmatic’s medications treatment. Reducing 
the smooth muscle airway with radio frequency thermo energy 
thereby reducing bronchoconstriction, the patient’s outcome 
would be fewer asthmatic attacks, fewer emergency rooms 
visits, and improved quality of life.
•  65 year-old male with asthma since childhood
•  FEV1 = 1.83L (55%)
•  Advair 500/50 twice a day, Xopenex, (levalbuterol), Metformin, 
Theophylline, Normalizer, Prednisone, Tricort
•  Allergic to Xolair
•  Two severe exacerbations in prior 12 months; 
   –  one requiring 8 days of hospitalization 
   –  5 courses of Prednisone in 12 months; side effects lead to obesity, diabetes, sleep 
apnea
•  Began to use walker and cane due to shortness of breath 
•  Onset of diabetes due to asthma
Patient Profile
Procedure:
•  Schedule as Outpatient Bronchoscopy with 
BT with a 90 minute timeline: physician 
requires 40-60 minutes to perform 
procedure
•  Administer anesthesia-assisted sedation or 
moderate sedation
Post Procedure:
•  Monitor for 2-4 hours
•  Repeat PFT; results must be within 80% of baseline pre-
procedure FEV1 (forced expiratory volume) 
•  Discharge with bronchoscopy criteria
Home Care Instructions:
•  Reinstruct patient to take next-day Oral Corticosteroid
•  Instruct patient to schedule office visit at 2-3 weeks to assess 
clinical stability for next treatment
•  Return patient to primary asthma physician care after completion 
of BT treatment
Bronchial thermoplasty, a minimally 
invasion procedure, improves a patient’s 
breathing capacity by delivering thermal 
energy to the airway wall to reduce the 
excessive airway smooth muscle (ASM). 
Reducing the size of the ASM decreases 
the ability of the airways to constrict, 
thereby reducing the frequency of asthma 
attacks. 
The Altair Bronchial Thermoplasty System 
is approved by FDA to treat severe 
persistent asthma patients 18 years and 
older where current treatment is not well 
controlled. 
The benefits of bronchial thermoplasty 
are decrease in severe asthma attacks, 
decrease in emergency room visits, and 
decrease in asthma symptoms.
Opportunities
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